SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 142 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $577,526 | -8.8% | 22,204 | 0.0% | 0.12% | -16.2% |
| Q3 2022 | $633,000 | +15.7% | 22,204 | 0.0% | 0.15% | +1.4% |
| Q2 2022 | $547,000 | -83.6% | 22,204 | -62.5% | 0.15% | -82.6% |
| Q1 2022 | $3,341,000 | -61.6% | 59,204 | -57.8% | 0.84% | -50.1% |
| Q4 2021 | $8,694,000 | -19.3% | 140,267 | -17.4% | 1.69% | -0.2% |
| Q3 2021 | $10,775,000 | -23.0% | 169,852 | 0.0% | 1.69% | -2.1% |
| Q2 2021 | $13,998,000 | +12.0% | 169,852 | 0.0% | 1.73% | -25.0% |
| Q1 2021 | $12,496,000 | -34.4% | 169,852 | -35.3% | 2.30% | +20.4% |
| Q4 2020 | $19,042,000 | +0.4% | 262,572 | -34.0% | 1.92% | -63.8% |
| Q3 2020 | $18,973,000 | -18.9% | 398,017 | -28.6% | 5.29% | -29.7% |
| Q2 2020 | $23,409,000 | +38.7% | 557,356 | -10.9% | 7.53% | -22.5% |
| Q1 2020 | $16,883,000 | -32.9% | 625,281 | -4.3% | 9.72% | -19.4% |
| Q4 2019 | $25,153,000 | +71.5% | 653,502 | -3.4% | 12.05% | +20.7% |
| Q3 2019 | $14,669,000 | – | 676,602 | – | 9.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |